Next Article in Journal
MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells
Next Article in Special Issue
Immune Checkpoint Ligand Reverse Signaling: Looking Back to Go Forward in Cancer Therapy
Previous Article in Journal
Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro
Previous Article in Special Issue
Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological Features
 
 
Article

Article Versions Notes

Cancers 2019, 11(4), 567; https://doi.org/10.3390/cancers11040567
Action Date Notes Link
article xml file uploaded 21 April 2019 10:22 CEST Original file -
article xml uploaded. 21 April 2019 10:22 CEST Update https://www.mdpi.com/2072-6694/11/4/567/xml
article pdf uploaded. 21 April 2019 10:22 CEST Version of Record https://www.mdpi.com/2072-6694/11/4/567/pdf
article supplementary file uploaded. 21 April 2019 10:22 CEST - https://www.mdpi.com/2072-6694/11/4/567#supplementary
article html file updated 21 April 2019 10:23 CEST Original file -
article html file updated 25 April 2019 08:40 CEST Update -
article html file updated 9 May 2019 19:59 CEST Update -
article html file updated 18 October 2019 18:07 CEST Update -
article html file updated 12 February 2020 06:49 CET Update -
article html file updated 19 July 2022 17:45 CEST Update https://www.mdpi.com/2072-6694/11/4/567/html
Back to TopTop